Innovaderm   Report issue

For profit Phase 1 Phase 2 Phase 3 Phase 4
Founded: Montreal Canada (1999)

Organization Overview

First Clinical Trial
2004
NCT00244842
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Innovaderm Research | Innovaderm Research Inc. | Innovaderm Research Incorporated | Medical Director

Active Ingredients

Drugs in Phase 4 Trials (11)

abrocitinib (Cibinqo) (1 trial)

adalimumab (humira) (5 trials)

apremilast (otezla) (1 trial)

bimekizumab (Bimzelx) (1 trial)

calcipotriene (dovonex) (1 trial)

crisaborole (eucrisa) (1 trial)

dupilumab (dupixent) (1 trial)

etanercept (enbrel) (4 trials)

live attenuated varicella vaccine (Varivax) (1 trial)

tazarotene (tazorac) (1 trial)

triamcinolone (kenalog) (1 trial)

Drugs in Phase 3 Trials (7)

acitretin (soriatane) (1 trial)

brimonidine (alphagan) (1 trial)

incobotulinumtoxinA (Xeomin) (1 trial)

infliximab (remicade) (1 trial)

methyl aminolevulinate (metvixia) (2 trials)

ustekinumab (stelara) (1 trial)

voclosporin (Lupkynis) (2 trials)

Drugs in Phase 2 Trials (13)

adx-914 (1 trial)

ak3280 (2 trials)

aqx-1125 (1 trial)

bmx-010 (1 trial)

eb01 (1 trial)

esr-114 (1 trial)

ifx-1 (1 trial)

lemuteporfin (1 trial)

losartan (cozaar) (1 trial)

nb-002 (1 trial)

ndi-034858 (1 trial)

stk-001 (2 trials)

tapinarof (Vtama) (3 trials)

Drugs in Phase 1 Trials (9)

atg-101 (1 trial)

cl-197 (1 trial)

denosumab (prolia) (1 trial)

diphencyprone (1 trial)

eras-801 (1 trial)

frtx-02 (1 trial)

pirfenidone (esbriet) (1 trial)

ruxolitinib (jakafi) (1 trial)

sodium chloride (2 trials)

Drugs in Other Trials (15)

benzoyl peroxide (clearasil) (1 trial)

biotin (1 trial)

canola oil (1 trial)

collagen (1 trial)

glycerin (1 trial)

lipohydroxy acid (1 trial)

mycophenolate (CellCept) (1 trial)

nicotine (nicorette) (1 trial)

prednisone (meticorten) (1 trial)

shea butter (1 trial)

sodium lauryl sulfate (1 trial)

tacrolimus (prograf) (1 trial)

tretinoin (Retin-A) (1 trial)

vitamin d3 (1 trial)

vitamin e (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Acne Vulgaris (Phase 2)

Apnea (Phase 4)

Arthritis (Phase 4)

Arthritis, Rheumatoid (Phase 4)

Atherosclerosis (Phase 4)

Back Pain (Phase 3)

Chickenpox (Phase 4)

Coronary Artery Disease (Phase 4)

Crohn Disease (Phase 4)

Dermatitis (Phase 4)

Dermatitis, Allergic Contact (Phase 2)

Dermatitis, Atopic (Phase 4)

Dermatitis, Contact (Phase 2)

Eczema (Phase 2)

Epilepsies, Myoclonic (Phase 2)

Erythema (Phase 3)

Herpes Zoster (Phase 4)

Hypersensitivity (Phase 1)

Hypersensitivity, Delayed (Phase 1)

Inflammation (Phase 4)

Keratosis (Phase 3)

Keratosis, Actinic (Phase 3)

Myocardial Ischemia (Phase 4)

Onychomycosis (Phase 2)

Psoriasis (Phase 4)

Pyoderma (Phase 2)

Pyoderma Gangrenosum (Phase 2)

Rosacea (Phase 3)

Sleep Apnea, Obstructive (Phase 4)

Sleep Apnea Syndromes (Phase 4)

Syndrome (Phase 2)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 59
  • # of Trial APIs: 55